Table 2.
Sample | Status | del(17p), % | CD138+, % | CD46 MFIR | Death, % | GFP, % | GFP MFIR |
---|---|---|---|---|---|---|---|
1 | MM | 0 | 13 | 46 | 58 | 54 | 10 |
2 | PCL | 0 | 30 | 47 | 65 | 68 | 10 |
3 | PCL | 0 | 34 | 202 | 46 | 96 | 19 |
4 | PCL | 0 | 7 | 36 | 47 | 42 | 6 |
5 | PCL | 0 | 16 | 60 | 76 | 50 | 14 |
6 | MM | 0 | 19 | 300 | 49 | 20 | 10 |
7 | MM | 0 | 60 | 353 | 40 | 80 | 14 |
8 | PCL | 0 | 63 | 87 | 67 | 91 | 31 |
9 | PE | 0 | 73 | 22 | 41 | 26 | 13 |
10 | MM | 11 | 7 | 100 | 76 | 62 | 9 |
11 | PCL | 88 | 40 | 237 | 78 | 58 | 16 |
12 | PCL | 89 | 29 | 200 | 38 | 53 | 17 |
13 | PCL | 94 | 41 | 26 | 58 | 90 | 6 |
14 | PCL | 100 | 21 | 124 | 77 | 94 | 17 |
CD46 expression was assessed in double staining with anti-CD138 mAb after isolation of mononuclear cells. Total mononuclear cells were incubated for 4 days with MV-GFP (MOI = 1). GFP expression in CD138+ cells represents the percentage of positive cells and the fluorescence intensity of the positive population. Cell death was determined by the percentage of loss of CD138+ cells. MFIR, CD46, and control mean fluorescence intensity values are provided in supplemental Table 1B.
PE, pleural effusion.